BP
Ben Gil Price

Ben Gil Price insider trades: Rexahn Pharmaceuticals (RNN) stock purchases

Rexahn Pharmaceuticals Last trade Jan 29, 2019 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2008
4
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ben reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 29, 2019RNN↑ Buy$9K
Mar 14, 2016SRPT↑ Buy$75K
Aug 19, 2013SRPT↑ Buy$16K
Mar 14, 2012AVII↑ Buy$39K
Apr 6, 2011AVII↑ Buy$30K
Aug 13, 2010AVII↑ Buy$8K
Jun 11, 2010AVII↑ Buy$10K
May 13, 2010AVII↑ Buy$54K
Mar 16, 2009AVII↑ Buy$33K
Aug 15, 2008AVII↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ben Gil Price's insider trades

Ben Gil Price is an insider at Rexahn Pharmaceuticals (RNN). Since Aug 15, 2008, Ben has reported 10 open-market purchases worth $282K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RNN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.